Leanne R De Souza1, Eva Kogan2, Howard Berger3, João G Alves4, Gerald Lebovic5, Ravi Retnakaran6, Jonathon L Maguire7, Joel G Ray8. 1. Department of Obstetrics and Gynecology, St. Michael's Hospital, Toronto ON; Institute of Medical Science, University of Toronto, Toronto ON. 2. Department of Obstetrics and Gynecology, St. Michael's Hospital, Toronto ON. 3. Department of Obstetrics and Gynecology, St. Michael's Hospital, Toronto ON; Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto ON. 4. Instituto de Medicina Integral Prof Fernando Figueira (IMIP), Recife, Brazil. 5. Department of Health Policy Management Evaluation, University of Toronto, Toronto ON. 6. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto ON. 7. Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto ON. 8. Department of Obstetrics and Gynecology, St. Michael's Hospital, Toronto ON; Institute of Medical Science, University of Toronto, Toronto ON; Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto ON; Department of Health Policy Management Evaluation, University of Toronto, Toronto ON; Department of Medicine, St. Michael's Hospital, Toronto ON.
Abstract
BACKGROUND: High pre-pregnancy body mass index is a known risk factor for gestational diabetes mellitus, but the contribution of abdominal adiposity to insulin resistance (IR) in pregnancy is not well understood. We assessed the association between abdominal adiposity in early pregnancy and IR. METHODS: We completed a prospective cohort study of 79 pregnant women. Visceral adipose tissue (VAT) depth was measured by ultrasonography at 11 to 14 weeks' gestation, at the time of routine fetal nuchal translucency assessment. A two-hour 75 g oral glucose tolerance test was subsequently completed at 16 to 22 weeks' gestation and IR was estimated by the homeostatic model assessment of insulin resistance (HOMA-IR) as well as by the insulin sensitivity index. RESULTS: After adjusting for maternal age, parity, ethnicity, and pre-pregnancy BMI, VAT depth explained 42% of the variance in HOMA-IR, which was slightly better than the variance in the multivariable model examining HOMA-IR and pre-pregnancy BMI (40%). For the insulin sensitivity index, the model variance values were 36% and 32%, respectively. CONCLUSION: Measurement of maternal adipose tissue depth at the time of routine first-trimester ultrasonography may provide additional information about maternal IR, beyond pre-pregnancy BMI.
BACKGROUND: High pre-pregnancy body mass index is a known risk factor for gestational diabetes mellitus, but the contribution of abdominal adiposity to insulin resistance (IR) in pregnancy is not well understood. We assessed the association between abdominal adiposity in early pregnancy and IR. METHODS: We completed a prospective cohort study of 79 pregnant women. Visceral adipose tissue (VAT) depth was measured by ultrasonography at 11 to 14 weeks' gestation, at the time of routine fetal nuchal translucency assessment. A two-hour 75 g oral glucose tolerance test was subsequently completed at 16 to 22 weeks' gestation and IR was estimated by the homeostatic model assessment of insulin resistance (HOMA-IR) as well as by the insulin sensitivity index. RESULTS: After adjusting for maternal age, parity, ethnicity, and pre-pregnancy BMI, VAT depth explained 42% of the variance in HOMA-IR, which was slightly better than the variance in the multivariable model examining HOMA-IR and pre-pregnancy BMI (40%). For the insulin sensitivity index, the model variance values were 36% and 32%, respectively. CONCLUSION: Measurement of maternal adipose tissue depth at the time of routine first-trimester ultrasonography may provide additional information about maternal IR, beyond pre-pregnancy BMI.
Entities:
Keywords:
body mass index; central adiposity; gestational diabetes; glucose handling; insulin resistance; insulin sensitivity index; obesity
Authors: Andrea Cardoso Pontual; José Natal Figueiroa; Leanne R De Souza; Joel G Ray; João Guilherme Bezerra Alves Journal: Matern Child Health J Date: 2016-08
Authors: L R De Souza; H Berger; R Retnakaran; P A Vlachou; J L Maguire; A B Nathens; P W Connelly; J G Ray Journal: Nutr Diabetes Date: 2016-09-19 Impact factor: 5.097
Authors: João Guilherme Alves; Alex Sandro Rolland Souza; José Natal Figueiroa; Carla Adriane Leal de Araújo; Angélica Guimarães; Joel Geoffrey Ray Journal: Sci Rep Date: 2020-02-06 Impact factor: 4.379
Authors: Alexandra Cremona; Kevin Hayes; Clodagh S O'Gorman; Ciara Ní Laighin; Khadijah I Ismail; Alan E Donnelly; Jill Hamilton; Amanda Cotter Journal: BMC Med Imaging Date: 2019-12-17 Impact factor: 1.930
Authors: Julia Bandres-Meriz; Anna M Dieberger; Denise Hoch; Caroline Pöchlauer; Martina Bachbauer; Andreas Glasner; Tobias Niedrist; Mireille N M van Poppel; Gernot Desoye Journal: Front Endocrinol (Lausanne) Date: 2020-10-09 Impact factor: 5.555